Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Welkos

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Archives of Microbiology|October 15, 2016
Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in miceR C Bernhards, C K Cote, K Amemiya, et al.
Vaccine|July 31, 1998
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccineD G Heath, G W Anderson, J M Mauro, et al.
The American Journal of Tropical Medicine and Hygiene|April 1, 1997
Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestisG W Anderson, P L Worsham, C R Bolt, et al.
Infection and Immunity|November 1, 1996
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestisG W Anderson, S E Leary, E D Williamson, et al.
Archives of Pathology & Laboratory Medicine|August 1, 1997
Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected miceK J Davis, P Vogel, D L Fritz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestisA M Friedlander, S L Welkos, P L Worsham, et al.
Journal of Applied Microbiology|February 14, 2017
Comparison of sampling methods to recover germinated Bacillus anthracis and Bacillus thuringiensis endospores from surface couponsT M Mott, J L Shoe, M Hunter, et al.
Infection and Immunity|February 20, 1999
Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestisG P Andrews, S T Strachan, G E Benner, et al.
Journal of Applied Microbiology|August 10, 2013
D-cycloserine or similar physiochemical compounds may be uniquely suited for use in Bacillus anthracis spore decontamination strategiesT O Omotade, J D Heffron, C P Klimko, et al.
Journal of Medical Microbiology|July 7, 2012
Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemiaC K Cote, L Kaatz, J Reinhardt, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Archives of Microbiology|October 15, 2016
Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in miceR C Bernhards, C K Cote, K Amemiya, et al.
Vaccine|July 31, 1998
Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccineD G Heath, G W Anderson, J M Mauro, et al.
The American Journal of Tropical Medicine and Hygiene|April 1, 1997
Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestisG W Anderson, P L Worsham, C R Bolt, et al.
Infection and Immunity|November 1, 1996
Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestisG W Anderson, S E Leary, E D Williamson, et al.
Archives of Pathology & Laboratory Medicine|August 1, 1997
Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected miceK J Davis, P Vogel, D L Fritz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 1, 1995
Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestisA M Friedlander, S L Welkos, P L Worsham, et al.
Journal of Applied Microbiology|February 14, 2017
Comparison of sampling methods to recover germinated Bacillus anthracis and Bacillus thuringiensis endospores from surface couponsT M Mott, J L Shoe, M Hunter, et al.
Infection and Immunity|February 20, 1999
Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestisG P Andrews, S T Strachan, G E Benner, et al.
Journal of Applied Microbiology|August 10, 2013
D-cycloserine or similar physiochemical compounds may be uniquely suited for use in Bacillus anthracis spore decontamination strategiesT O Omotade, J D Heffron, C P Klimko, et al.
Journal of Medical Microbiology|July 7, 2012
Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemiaC K Cote, L Kaatz, J Reinhardt, et al.
Pageof 6